Copyright
©The Author(s) 2016.
World J Gastroenterol. Feb 28, 2016; 22(8): 2512-2523
Published online Feb 28, 2016. doi: 10.3748/wjg.v22.i8.2512
Published online Feb 28, 2016. doi: 10.3748/wjg.v22.i8.2512
Group | n | Daily food consumption (g) | Liver weight (g) | Hepatic TG (mg/g liver) | Hepatic FFA (mg/g liver) | Serum ALT (IU/L) |
MCS 4 wk | 6 | 6.4 ± 0.5 | 2.3 ± 0.03 | 102 ± 30 | 0.82 ± 0.06 | 30 ± 5.4 |
MCD + saline 4 wk | 8 | 3.4 ± 0.5b | 1.6 ± 0.02b | 314 ± 17b | 1.24 ± 0.18b | 209 ± 30b |
MCD + exendin-4 4 wk | 8 | 3.2 ± 0.6 | 1.3 ± 0.04d | 200 ± 40d | 1.05 ± 0.11 | 190 ± 29 |
MCS 8 wk | 6 | 6.2 ± 0.5 | 2.2 ± 0.03 | 43 ± 9 | 0.64 ± 0.01 | 32 ± 16 |
MCD + saline 8 wk | 8 | 3.4 ± 0.4a | 1.4 ± 0.04a | 137 ± 31a | 0.87 ± 0.06a | 103 ± 41a |
MCD + exendin-4 8 wk | 8 | 3.0 ± 0.6 | 1.1 ± 0.03c | 96 ± 19 | 0.69 ± 0.06 | 81 ± 24 |
- Citation: Yamamoto T, Nakade Y, Yamauchi T, Kobayashi Y, Ishii N, Ohashi T, Ito K, Sato K, Fukuzawa Y, Yoneda M. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice. World J Gastroenterol 2016; 22(8): 2512-2523
- URL: https://www.wjgnet.com/1007-9327/full/v22/i8/2512.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i8.2512